• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Dashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlerts
    Company
    AboutQuantisnow PlusContactJobs
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form 4: Greskoviak Joseph P returned $237,555 worth of shares to the company (79,185 units at $3.00), closing all direct ownership in the company (for withholding tax)

    4/7/22 4:19:44 PM ET
    $TLMD
    Managed Health Care
    Health Care
    Get the next $TLMD alert in real time by email
    SEC FORM 4 SEC Form 4
    FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549

    STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

    Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
    or Section 30(h) of the Investment Company Act of 1940
    OMB APPROVAL
    OMB Number: 3235-0287
    Estimated average burden
    hours per response: 0.5
    X
    Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
    1. Name and Address of Reporting Person*
    Greskoviak Joseph P

    (Last) (First) (Middle)
    C/O SOC TELEMED, INC.
    2411 DULLES CORNER PARK, SUITE 475

    (Street)
    HERNDON VA 20171

    (City) (State) (Zip)
    2. Issuer Name and Ticker or Trading Symbol
    SOC Telemed, Inc. [ TLMD ]
    5. Relationship of Reporting Person(s) to Issuer
    (Check all applicable)
    Director 10% Owner
    Officer (give title below) X Other (specify below)
    Former Director
    3. Date of Earliest Transaction (Month/Day/Year)
    04/06/2022
    4. If Amendment, Date of Original Filed (Month/Day/Year)
    6. Individual or Joint/Group Filing (Check Applicable Line)
    X Form filed by One Reporting Person
    Form filed by More than One Reporting Person
    Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
    1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
    Code V Amount (A) or (D) Price
    Class A Common Stock 04/06/2022 D(1) 79,185 D $3 0 D
    Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
    (e.g., puts, calls, warrants, options, convertible securities)
    1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
    Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
    Explanation of Responses:
    1. On April 6, 2022, pursuant to the Agreement and Plan of Merger (the "Merger Agreement"), dated as of February 2, 2022, by and among SOC Telemed, Inc. (the "Issuer"), Spark Parent, Inc. ("Parent") and Spark Merger Sub, Inc. ("Merger Sub"), pursuant to which Merger Sub was merged with and into the Issuer (the "Merger"), with the Issuer surviving the Merger as a direct, wholly owned subsidiary of Parent, each share of the Issuer's Class A Common Stock (other than certain excluded shares) outstanding as of immediately prior to the effective time of the Merger (the "Effective Time") was canceled and automatically converted into the right to receive an amount in cash equal to $3.00 (the "Merger Consideration"), without any interest thereon and subject to any applicable withholding taxes.
    Remarks:
    /s/ Eunice Kim, as Attorney-in-Fact 04/07/2022
    ** Signature of Reporting Person Date
    Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
    * If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
    ** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
    Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
    Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
    Get the next $TLMD alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $TLMD

    DatePrice TargetRatingAnalyst
    4/1/2022$3.00Neutral
    Credit Suisse
    2/7/2022$2.00 → $3.00Neutral
    Credit Suisse
    2/4/2022Buy → Hold
    Benchmark
    2/3/2022$6.00 → $3.00Outperform → Sector Perform
    RBC Capital
    2/3/2022$4.00 → $3.00Outperform → Neutral
    Baird
    1/7/2022$6.00 → $2.00Outperform → Neutral
    Credit Suisse
    8/13/2021$10.00 → $6.00Outperform
    RBC Capital
    8/13/2021$11.00 → $8.50Outperform
    Credit Suisse
    More analyst ratings

    $TLMD
    Financials

    Live finance-specific insights

    See more
    • SOC Telemed Reports Third Quarter 2021 Financial and Operating Results

      RESTON, Va., Nov. 12, 2021 /PRNewswire/ -- SOC Telemed, Inc., (NASDAQ:TLMD), the largest national provider of acute care telemedicine, today announced its financial and operating results for the third quarter ending September 30, 2021. SOC Telemed Reports Third Quarter 2021 Financial and Operating Results "We are proud of our third quarter results as the new organization came together with renewed focus resulting in the highest quarterly revenue and bookings in our company's history," said Dr. Chris Gallagher, Chief Executive Officer. "Upon joining the Company, my first task h

      11/12/21 7:00:00 AM ET
      $TLMD
      Managed Health Care
      Health Care
    • SOC Telemed to Provide Corporate and Financial Update for the Third Quarter 2021 on November 12, 2021

      RESTON, Va., Oct. 29, 2021 /PRNewswire/ -- SOC Telemed, Inc. (NASDAQ:TLMD), the largest national provider of acute care telemedicine, today announced that the company will provide a corporate and financial update for the third quarter 2021, on Friday, November 12, 2021, before market open. SOC Telemed's management team will host a conference call and live audio webcast at 8:00 a.m. ET. To participate in the call, dial either the domestic or international number or join the webcast from your computer or mobile phone. Domestic: (877) 292-0959 International: (412) 542-4143 Passco

      10/29/21 7:00:00 AM ET
      $TLMD
      Managed Health Care
      Health Care
    • SOC Telemed Announces Introductory Conference Call with New Leadership

      RESTON, Va., Sept. 7, 2021 /PRNewswire/ -- SOC Telemed, Inc. (NASDAQ:TLMD), the largest national provider of acute care telemedicine, today announced that the Company will host an introductory conference call with new leadership, which was announced on September 1, 2021. Dr. Chris Gallagher, CEO of the Company, and Joe Greskoviak, Vice Chairman of the Board of Directors, will host the call on Thursday, September 9, 2021, at 5 p.m. ET. Dial-In Numbers Domestic: (877) 292-0959 International: (412) 542-4143 Passcode: please ask to join the SOC Telemed call A live audio webcast w

      9/7/21 4:05:00 PM ET
      $TLMD
      Managed Health Care
      Health Care

    $TLMD
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • SEC Form 4: Warburg Pincus & Co. returned $101,624,895 worth of shares to the company (33,874,965 units at $3.00)

      4 - SOC Telemed, Inc. (0001791091) (Issuer)

      4/7/22 4:45:23 PM ET
      $TLMD
      Managed Health Care
      Health Care
    • SEC Form 4: Warburg Pincus & Co. returned $101,624,895 worth of shares to the company (33,874,965 units at $3.00)

      4 - SOC Telemed, Inc. (0001791091) (Issuer)

      4/7/22 4:44:31 PM ET
      $TLMD
      Managed Health Care
      Health Care
    • SEC Form 4: Shulman Steven J returned $3,336,873 worth of shares to the company (1,112,291 units at $3.00), closing all direct ownership in the company (tax liability)

      4 - SOC Telemed, Inc. (0001791091) (Issuer)

      4/7/22 4:29:25 PM ET
      $TLMD
      Managed Health Care
      Health Care

    $TLMD
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • SEC Form SC 13D/A filed by SOC Telemed Inc. (Amendment)

      SC 13D/A - SOC Telemed, Inc. (0001791091) (Subject)

      4/7/22 4:47:02 PM ET
      $TLMD
      Managed Health Care
      Health Care
    • SEC Form SC 13G filed by SOC Telemed Inc.

      SC 13G - SOC Telemed, Inc. (0001791091) (Subject)

      3/24/22 4:10:01 PM ET
      $TLMD
      Managed Health Care
      Health Care
    • SEC Form SC 13G/A filed by SOC Telemed Inc. (Amendment)

      SC 13G/A - SOC Telemed, Inc. (0001791091) (Subject)

      2/14/22 3:54:05 PM ET
      $TLMD
      Managed Health Care
      Health Care

    $TLMD
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Credit Suisse resumed coverage on SOC Telemed with a new price target

      Credit Suisse resumed coverage of SOC Telemed with a rating of Neutral and set a new price target of $3.00

      4/1/22 7:17:19 AM ET
      $TLMD
      Managed Health Care
      Health Care
    • Credit Suisse reiterated coverage on SOC Telemed with a new price target

      Credit Suisse reiterated coverage of SOC Telemed with a rating of Neutral and set a new price target of $3.00 from $2.00 previously

      2/7/22 8:24:46 AM ET
      $TLMD
      Managed Health Care
      Health Care
    • SOC Telemed downgraded by Benchmark

      Benchmark downgraded SOC Telemed from Buy to Hold

      2/4/22 6:36:59 AM ET
      $TLMD
      Managed Health Care
      Health Care

    $TLMD
    SEC Filings

    See more
    • SEC Form 15-12B filed by SOC Telemed Inc.

      15-12B - SOC Telemed, Inc. (0001791091) (Filer)

      4/18/22 7:00:34 AM ET
      $TLMD
      Managed Health Care
      Health Care
    • SEC Form EFFECT filed by SOC Telemed Inc.

      EFFECT - SOC Telemed, Inc. (0001791091) (Filer)

      4/11/22 12:15:22 AM ET
      $TLMD
      Managed Health Care
      Health Care
    • SEC Form EFFECT filed by SOC Telemed Inc.

      EFFECT - SOC Telemed, Inc. (0001791091) (Filer)

      4/11/22 12:15:28 AM ET
      $TLMD
      Managed Health Care
      Health Care

    $TLMD
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Securonix Appoints Eunice Kim as General Counsel

      Veteran Legal Executive Brings More Than Two Decades of Experience in Private and Public Sector Regulatory Affairs, Ethics and Compliance to Unified Defense SIEM Leader Securonix, Inc., a leader in Unified Defense SIEM, today announced the appointment of Eunice Kim as general counsel. In this role, Kim will be responsible for leading Securonix's legal and compliance functions, enhancing processes for evaluating expansion and growth opportunities, and implementing corporate policies that support the company's mission, vision and values. "Eunice is a dynamic legal executive, and we are thrilled to welcome her to Securonix," said Nayaki Nayyar, Chief Executive Officer, Securonix. "Her prov

      11/30/23 10:00:00 AM ET
      $TLMD
      Managed Health Care
      Health Care
    • SOC Telemed Completes Acquisition by Patient Square Capital

      HERNDON, Va., April 6, 2022 /PRNewswire/ -- SOC Telemed, Inc. (NASDAQ:TLMD) (the "Company" or "SOC Telemed"), the largest national provider of acute care telemedicine, today announced the completion of its previously announced transaction to be acquired by Patient Square Capital, a leading dedicated health care investment firm, in an all-cash transaction. The acquisition was previously announced on February 3, 2022, and SOC Telemed's stockholders approved the transaction at the Special Meeting of Stockholders held on April 4, 2022. Upon completion of the acquisition, SOC Telemed stockholders received $3.00 in cash per share of Class A common stock. SOC Telemed's Class A common stock and warr

      4/6/22 7:45:00 AM ET
      $TLMD
      Managed Health Care
      Health Care
    • SOC Telemed Stockholders Approve Acquisition by Patient Square Capital

      HERNDON, Va., April 4, 2022 /PRNewswire/ -- SOC Telemed, Inc. (NASDAQ:TLMD) (the "Company" or "SOC Telemed"), the largest national provider of acute care telemedicine, today announced that its stockholders approved the acquisition of SOC Telemed by Patient Square Capital, a leading dedicated health care investment firm, at a special meeting. Steve Shulman, Chairman of the SOC Telemed Board of Directors, said, "On behalf of the SOC Telemed Board, I would like to thank our stockholders for their support of this transaction. Today's vote represents an important milestone towards

      4/4/22 4:18:00 PM ET
      $TLMD
      Managed Health Care
      Health Care

    $TLMD
    Leadership Updates

    Live Leadership Updates

    See more
    • Anne McGeorge, Former Managing Partner of Grant Thornton LLP, Joins CitiusTech’s Board of Directors and Chair of the Audit Committee

      PRINCETON, N.J.--(BUSINESS WIRE)--CitiusTech, a leading provider of healthcare technology services and solutions, announced today that Anne McGeorge, former Managing Partner of Grant Thornton’s Global Health Care and Life Sciences Practices, has joined its Board of Directors and chair of the Audit Committee. Ms. McGeorge comes with over 35 years of experience advising healthcare clients in all aspects of finance and transformational change, including strategy, M&A, joint ventures, financial statement audits, corporate restructuring, governance, talent acquisition, executive compensation, IRS matters and risk management. She created the healthcare / life sciences practice for Gran

      1/12/21 9:07:00 AM ET
      $TLMD
      $MGTA
      Managed Health Care
      Health Care
      Biotechnology: Pharmaceutical Preparations